https://doi.org/10.1038/s41388-019-0700-2
V
Valeria Cancila
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
263
Papers
2.9K
Citations
25
h-index
48
i10-index
Valeria Cancila is an academic researcher from Department of Health. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer Research and Treatments & CAR-T cell therapy research. The author has an h-index of 25, co-authored 224 publications.
ORCID: 0000-0002-9502-1191Papers by this author
worksWNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
2019 · Oncogene · 179 citations
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance
2016 · Cell Death and Disease · 140 citations
https://doi.org/10.1038/cddis.2016.175
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome
2020 · Nature Communications · 92 citations
https://doi.org/10.1038/s41467-020-17596-5
Infiltrating Mast Cell–Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype
2020 · Cancer Research · 54 citations
https://doi.org/10.1158/0008-5472.can-19-3596
The prolyl-isomerase PIN1 is essential for nuclear Lamin-B structure and function and protects heterochromatin under mechanical stress
2021 · Cell Reports · 37 citations
https://doi.org/10.1016/j.celrep.2021.109694
Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
2023 · Journal of Experimental & Clinical Cancer Research · 23 citations
https://doi.org/10.1186/s13046-023-02731-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat